Modeling the role of genetic factors in characterizing extra-intestinal manifestations in Crohn's disease patients: does this improve outcome predictions?

Author： Giachino Daniela F.   Regazzoni Silvia   Bardessono Marco   De Marchi Mario   Gregori Dario    

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.7, 2007-07, pp. : 1657-1665

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: vedolizumab as a treatment and cause of extra‐intestinal manifestations of inflammatory bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 535-536

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 485-493

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence and Risk Factors for Urolithiasis in Patients with Crohn's Disease

By  

Urologia Internationalis, Vol. 95, Iss. 3, 2015-0 ,pp. : 314-319

Karger

Access to resources Recommend Favorite

Extraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and management

By Larsen Signe   Bendtzen Klaus   Nielsen Ole Haagen  

Annals of Medicine, Vol. 42, Iss. 2, 2010-02 ,pp. : 97-114

Informa Healthcare

Access to resources Recommend Favorite

Factors affecting the fate of faecal diversion in patients with perianal Crohn's disease

By  

COLORECTAL DISEASE, Vol. 17, Iss. 1, 2015-01 ,pp. : 66-72

John Wiley & Sons Inc

Access to resources Recommend Favorite